porcin
parvoviru
ppv
caus
reproduct
failur
swine
result
econom
loss
industri
antivir
effect
diammonium
glycyrrhizin
dg
report
sever
anim
virus
howev
date
yet
test
ppv
studi
antivir
activ
dg
swine
testi
st
cell
infect
ppv
investig
use
empir
determin
nontox
concentr
dg
three
differ
experiment
design
pretreat
viru
prior
infect
pretreat
cell
prior
infect
direct
treatment
virusinfect
cell
result
show
dg
possess
potent
inhibitori
effect
ppv
viru
treat
incub
st
cell
viru
infect
decreas
dosedepend
manner
result
confirm
indirect
immunofluoresc
assay
realtim
quantit
pcr
addit
deoxychol
use
control
exclud
possibl
dg
act
deterg
inhibit
ppv
infect
studi
clearli
indic
dg
direct
antippv
effect
vitro
pengchong
li
hao
zou
cofirst
author
porcin
parvoviru
ppv
belong
famili
parvovirida
exist
singlestrand
minusstrand
dna
viru
base
length
ppv
among
common
import
caus
infecti
infertil
pig
result
signific
econom
loss
swine
industri
one
virus
surviv
environ
extend
period
time
refractori
disinfect
current
viabl
treatment
diseas
vaccin
effect
cost
safeti
issu
deterr
routin
vaccin
mani
region
world
porcin
parvoviru
first
report
mahnel
et
al
upon
cultur
swine
fever
viru
subsequ
isol
diseas
pig
major
clinic
symptom
ppv
diseas
includ
miscarriag
stillbirth
mummifi
piglet
newborn
piglet
death
diseas
found
worldwid
sinc
earli
present
attenu
kill
viral
vaccin
use
control
ppv
infect
howev
attenu
vaccin
stand
danger
restructur
reacquir
virul
furthermor
evid
advanc
vaccin
ppv
may
protect
diseas
necessarili
prevent
viral
infect
viru
shed
heterolog
strain
convent
use
ppv
vaccin
need
basi
provid
opportun
develop
drug
therapi
use
supplementari
control
strategi
diammonium
glycyrrhizin
dg
activ
ingredi
glycyrrhiza
extract
signific
antiinflammatori
effect
enhanc
liver
cell
protect
liver
function
compound
activ
human
immunodefici
viru
hiv
hepat
viru
hav
hepat
b
viru
hbv
coronaviru
herp
viru
studi
antivir
effect
dg
ppv
vitro
analyz
data
present
herein
indic
dg
decreas
infect
ppv
significantli
incub
viru
prior
contact
cell
swine
testi
st
cell
ppvsuscept
cell
line
maintain
laboratori
grown
dulbecco
modifi
eagl
medium
dmem
fetal
bovin
serum
co
ppv
strain
propag
st
cell
absenc
serum
use
infect
analys
cytotox
assay
perform
accord
publish
mtt
bromid
tetrazol
protocol
minor
modif
cell
monolay
plate
onto
cultur
plate
wash
three
time
phosphatebuff
salin
pb
dg
zhengda
pharmaci
china
serial
dilut
twofold
serumfre
dmem
ad
onto
well
well
per
dilut
mocktreat
cell
contain
dg
use
neg
control
cell
cultur
h
supplement
per
well
dmem
per
well
mtt
solut
incub
addit
h
wash
pb
dmso
ad
well
plate
shaken
gentli
min
dissolv
formazan
precipit
od
record
cell
surviv
rate
calcul
mean
valu
accord
follow
equat
od
drug
od
control
deoxychol
doc
sigma
china
serial
dilut
twofold
begin
mgml
serumfre
dmem
ad
st
cell
monolay
cultur
h
observ
cytopath
effect
st
cell
cultur
plate
treat
experiment
determin
nontox
concentr
dg
lgml
h
wash
three
time
pb
cell
subsequ
infect
ppv
tissu
cultur
infect
dose
tcid
h
mtt
assay
perform
describ
cell
surviv
rate
similarli
calcul
mean
valu
determin
effect
dg
ppvinfect
cell
st
cell
infect
ppv
h
treat
lgml
dg
h
wash
three
time
pb
cell
surviv
rate
calcul
use
mtt
assay
describ
investig
direct
effect
dg
viru
ppv
incub
lgml
dg
h
dgtreat
ppv
subsequ
use
infect
st
cell
previous
describ
briefli
confluent
st
cell
grown
plate
wash
three
time
pb
follow
infect
dgtreat
ppv
h
mtt
assay
perform
describ
calcul
cell
surviv
rate
immunofluoresc
realtim
pcr
indirect
immunofluoresc
assay
ifa
realtim
pcr
perform
confirm
quantifi
observ
inhibitori
effect
dg
ifa
st
cell
confluenc
incub
drugtreat
ppv
h
parallel
lgml
doc
use
treat
ppv
control
wash
pb
cell
fix
paraformaldehyd
pb
follow
quench
glycin
pb
min
wash
cell
incub
rabbit
antippv
antibodi
h
follow
incub
rhodamineconjug
goat
antirabbit
igg
zhongshan
china
min
dark
antibodi
dilut
bovin
serum
albumin
effect
dg
ppv
infect
quantifi
realtim
pcr
target
gene
ppv
viru
treat
increas
concentr
dg
h
doctreat
ppv
use
control
wash
pb
st
cell
confluenc
plate
incub
dgtreat
ppv
h
viruscontain
cultur
frozen
thaw
three
time
follow
incub
equal
volum
polyethylen
glycol
peg
min
room
temperatur
sampl
centrifug
g
min
pellet
suspend
dnasefre
water
total
dna
extract
commerci
kit
fastgen
china
accord
manufactur
instruct
subsequ
pcr
perform
use
abi
prism
realtim
pcr
machin
appli
biosystem
usa
pcr
mixtur
includ
dna
templat
lg
sybr
taq
polymeras
rox
refer
dye
ii
pmol
sens
primer
ca
actggcttcaagataatgctc
pmol
antisens
primer
tctttgtaggtctatcatttc
steril
water
pcr
paramet
follow
cycl
data
analysi
base
measur
cycl
threshold
ct
valu
express
level
ppv
first
normal
bactin
isol
total
dna
untreat
sampl
use
refer
treat
sampl
dct
ct
sampl
ct
bactin
use
measur
rel
amplif
use
ddct
method
experi
perform
triplic
statist
signific
evalu
use
test
spss
softwar
valu
p
consid
highli
signific
antivir
activ
glycyrrhizin
well
document
howev
vari
among
differ
virus
exampl
dissimilar
effect
viral
replic
observ
cultur
hiv
isol
depend
whether
isol
syncytiuminduc
variant
differ
link
abil
glycyrrhizin
induc
certain
cultur
cell
use
propag
viru
glycyrrhizin
inhibit
earli
stage
replic
hav
penetr
hav
plasma
membran
cell
alexand
hepatoma
cell
line
exhibit
virucid
inhibitori
effect
adsorpt
hav
guinea
pig
model
one
group
found
intraven
administ
glycyrrhizin
bound
hepatocyt
modifi
express
hbvrelat
antigen
hepatocyt
suppress
sialyl
hbsag
propos
one
mechan
intraven
inject
glycyrrhizin
improv
liver
function
result
occasion
complet
recoveri
hepat
previou
report
vitro
vivo
assay
indic
dg
antivir
activ
cell
infect
avian
infecti
bronchiti
viru
ibv
decreas
apoptosi
infect
cell
also
pharmacolog
activ
dg
pseudorabi
viru
prv
infect
evalu
use
viru
plaquereduct
assay
pcr
rtpcr
data
point
demonstr
inhibit
prv
infect
prvinduc
cell
apoptosi
howev
result
observ
prv
pretreat
dg
indic
cellular
factor
prv
might
involv
note
activ
dg
viru
infect
replic
variou
howev
current
report
effect
dg
ppv
infect
studi
show
maximum
nontox
concentr
dg
st
cell
viabil
prolifer
experiment
determin
lgml
indic
mtt
assay
well
observ
previou
studi
concentr
differ
dgtreat
cell
mocktreat
cell
rel
cell
morpholog
data
shown
doc
use
nontox
concentr
lgml
also
determin
experiment
cell
treat
dg
prior
ppv
infect
minim
antivir
effect
observ
cell
surviv
rate
low
slightli
better
viru
control
significantli
p
fig
signific
differ
howev
observ
cell
viru
control
group
p
effect
dg
ppvinfect
cell
indic
dg
also
significantli
reduc
infect
ppv
cell
surviv
rate
fig
ppv
pretreat
dg
use
infect
st
cell
signific
decreas
infect
observ
cell
surviv
rate
p
rel
control
fig
result
treatment
regimen
confirm
ifa
shown
fig
ppvinfect
st
cell
gener
strong
fluoresc
signal
h
postinfect
contrast
fluoresc
st
cell
infect
dgtreat
ppv
decreas
dosedepend
manner
although
inhibitori
effect
dg
ppvinfect
cell
lower
observ
dgpretreat
viru
high
cell
surviv
rate
still
import
circumst
antivir
therapi
use
anim
previous
diagnos
posit
given
differ
cell
pretreat
dg
wash
versu
cell
treat
dg
postinfect
viru
possibl
dg
intern
cell
function
intracellularli
bind
inactiv
viral
particl
within
cell
inde
current
research
target
find
way
bind
dg
nanoparticl
help
better
intern
drug
target
specif
cell
type
presenc
dg
may
meaning
effect
viru
even
enter
cell
result
clearli
show
dg
deactiv
ppv
use
doc
exclud
possibl
deterg
characterist
dg
caus
nonspecif
antivir
activ
inde
report
recent
oral
bioavail
glycyrrhizin
could
improv
formul
drug
associ
sodium
docphospholipidmix
nanomicel
sdcplmm
support
specif
natur
activ
ppv
group
treat
doc
fluoresc
signal
diminish
observ
quantifi
rtpcr
result
show
rel
amplif
ppvderiv
gene
decreas
dosedepend
manner
maximum
presenc
lgml
dg
coincid
decreas
ppv
infect
fig
realtim
pcr
perform
h
postppv
infect
result
show
time
point
dg
treatment
inhibit
cell
infect
data
shown
maximum
inhibit
occur
h
note
pretreat
st
cell
dg
result
signific
increas
cell
surviv
howev
treatment
ppv
prior
incub
st
cell
posit
influenc
cell
surviv
suggest
activ
dg
direct
indirect
contact
viru
essenti
prevent
infect
contrast
hypothes
suggest
dg
interact
cellrel
factor
viral
receptor
critic
prevent
infect
also
suggest
maintain
suffici
high
level
dg
necessari
prevent
progeni
viru
infect
new
cell
propag
infect
short
latent
period
import
benefici
therapeut
drug
ppv
seen
fig
dg
use
directli
treat
virusinfect
cell
extend
period
time
h
multipl
round
viru
replic
would
occur
base
observ
becom
import
identifi
mechan
bind
dg
ppv
well
virus
order
advanc
develop
newer
effect
therapi
virus
known
affect
dg
treatment
conclus
dg
neglig
advers
effect
st
cell
studi
reveal
dg
exhibit
direct
inhibit
ppv
vitro
may
consid
effect
antippv
agent
